1. Home
  2. SAIC vs AXSM Comparison

SAIC vs AXSM Comparison

Compare SAIC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAIC
  • AXSM
  • Stock Information
  • Founded
  • SAIC 1969
  • AXSM 2012
  • Country
  • SAIC United States
  • AXSM United States
  • Employees
  • SAIC 24000
  • AXSM N/A
  • Industry
  • SAIC EDP Services
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAIC Technology
  • AXSM Health Care
  • Exchange
  • SAIC Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • SAIC 5.6B
  • AXSM 5.1B
  • IPO Year
  • SAIC N/A
  • AXSM 2015
  • Fundamental
  • Price
  • SAIC $120.41
  • AXSM $119.10
  • Analyst Decision
  • SAIC Buy
  • AXSM Strong Buy
  • Analyst Count
  • SAIC 10
  • AXSM 16
  • Target Price
  • SAIC $131.40
  • AXSM $176.56
  • AVG Volume (30 Days)
  • SAIC 318.1K
  • AXSM 577.4K
  • Earning Date
  • SAIC 09-04-2025
  • AXSM 08-04-2025
  • Dividend Yield
  • SAIC 1.24%
  • AXSM N/A
  • EPS Growth
  • SAIC N/A
  • AXSM N/A
  • EPS
  • SAIC 7.14
  • AXSM N/A
  • Revenue
  • SAIC $7,509,000,000.00
  • AXSM $495,033,000.00
  • Revenue This Year
  • SAIC $4.21
  • AXSM $61.62
  • Revenue Next Year
  • SAIC $2.37
  • AXSM $59.02
  • P/E Ratio
  • SAIC $16.70
  • AXSM N/A
  • Revenue Growth
  • SAIC 3.39
  • AXSM 69.83
  • 52 Week Low
  • SAIC $94.68
  • AXSM $75.56
  • 52 Week High
  • SAIC $156.34
  • AXSM $139.13
  • Technical
  • Relative Strength Index (RSI)
  • SAIC 60.22
  • AXSM 66.25
  • Support Level
  • SAIC $116.20
  • AXSM $115.99
  • Resistance Level
  • SAIC $121.04
  • AXSM $120.50
  • Average True Range (ATR)
  • SAIC 2.45
  • AXSM 3.04
  • MACD
  • SAIC 0.13
  • AXSM 1.21
  • Stochastic Oscillator
  • SAIC 69.96
  • AXSM 79.43

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: